CD44 and colon carcinoma: By immunopurifying CD44 from PDGF-treated and untreated LS174T colon carcinoma cells, which express predominantly CD44v, and HL60 myeloid cells, which exclusively express CD44s, we demonstrated the divergent effects of PGDF on CD44v versus CD44s binding to fibrin.